Role of Cost-Sharing Subsidies on the Initiation of and Adherence to Tyrosine Kinase Inhibitor Therapy by Medicare Beneficiaries With Chronic Myeloid Leukemia
- PMID: 28524780
- DOI: 10.1200/JCO.2016.72.0011
Role of Cost-Sharing Subsidies on the Initiation of and Adherence to Tyrosine Kinase Inhibitor Therapy by Medicare Beneficiaries With Chronic Myeloid Leukemia
Comment in
-
Reply to E. Ritchie et al.J Clin Oncol. 2017 May 20;35(15):1745-1746. doi: 10.1200/JCO.2016.72.0037. Epub 2017 Feb 13. J Clin Oncol. 2017. PMID: 28524775 No abstract available.
Comment on
-
Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.J Clin Oncol. 2016 Dec 20;34(36):4323-4328. doi: 10.1200/JCO.2016.67.4184. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27998234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
